Quality e-Newsletter
Intelligence Unit Special Reports Special Events Subscribe Sponsored Departments Follow Us

Twitter Facebook LinkedIn RSS

It's Impossible to Know What $1B in Federal Quality Spending Buys

Cheryl Clark, for HealthLeaders Media, February 20, 2014

We just don't know. It might be that some initiatives at one hospital were so successful, they masked other initiatives at that same hospital that actually had a negative impact. Like taking every drug in the medicine cabinet to get over a cold; one never knows which pill did the trick, if any. And some drugs might have exacerbated symptoms.

"The Joint Commission, professional societies like the American College of Surgeons, and our bloodstream infection work has been implemented all over the country," all [these groups] have projects to reduce readmissions and reduce adverse events and costs," and many are working in the same hospitals, Pronovost says.

Like I said, much of this effort is funded by taxpayers. In all, some $500 million in federal funds is funding organizations in 102 communities through meals, transportation and home health agencies to help hospitals improve care after discharge, and reduce mortality and readmissions.

The Centers for Disease Control and Prevention has programs to reduce hospital acquired infections such as C. diff and MRSA, and other projects are run from the Agency for Healthcare Research and Quality. Numerous private endowments such as the Robert Wood Johnson Foundation work with hospitals as well. And don't forget the Quality Improvement Organizations, which work under CMS contracts with hospitals around the country too. And there are many others.

Some 25 other HENs are working with state hospital associations and other networks across the country using different strategies as well. And some hospitals might work with multiple HENs.

Don Goldmann, MD, chief medical and scientific officer for the Institute of Healthcare Improvement, agrees that there are problems with some of these programs, but says a lot of good will come from them eventually.

1 | 2 | 3 | 4 | 5

Comments are moderated. Please be patient.

3 comments on "It's Impossible to Know What $1B in Federal Quality Spending Buys"


Kate ONeill, MSN, RN (2/22/2014 at 8:00 PM)
Dear Cheryl, THANK YOU for post and a great read. Please let me share with you and the US taxpayers some interesting information. I'm the new VP of Quality and Safety at CloseCareGap, PSO. We were approved as a Patient Safety Organization in July 2013. Over the past 6 months, we have contacted many HEN organizations at the national and state level with little avail to collaborate with our benefit PSO organization. CCG has built a sustainable solution (real-time), a smart app, to measure variances and gaps in practice around the HEN top 10 core areas of harm. Our solution is FREE to hospital organizations and publicly available at http://www.icarequality.org/closecaregap.html . We have yet hear back from any HEN's who are interested in our solution to partner with us to collaborate and improve care delivery together at the bedside. Furthermore, when we submitted information about CCG to the federal agency in December 2013, they did not even have Nursing as a profile as a specialty discipline. How could the federal government not even have "Nursing" listed to help improve care delivery on the frontline? Where has billions of tax dollars been spent over the last few years since the notorious IOM report? Please feel free to comment or contact CCG if we can improve care delivery together. We welcome joint collaboration to improve care quality and safety. Patients and taxpayers expect more and deserve more if work together for a better solution. Kate at kate.oneill@icarequality.org

Sandra Trotter (2/22/2014 at 1:47 PM)
The two main themes seem to be about the data validity and the attributing the improvements solely to the HEN interventions. For the data validity- the top measures, which are used in the calculations,are all standard measures and definitions that many researchers use to validate improvements (NHSN,Joint Commission Core Measures,Leapfrog,CMS, etc). I agree it's not perfect data but it is a mistake to say that it is not standard data routinely used for healthcare quality comparisons. For attribution- no one can claim "sole" credit for hospital improvement because hospitals don't exist in a vacuum. This is even more true for these hospitals because collaboration is built in by design. The Hospital Engagement Networks (HENs) are part of Partnerships for Patients which is a coming together of many organizations including TJC, CMS, NQF, etc to share and learn from one another. I personally think this is a very exciting time in healthcare. I work with hospitals in California and I am seeing across the state, great strides to improve patient safety and quality of care at our hospitals. Sandra Trotter, MBA, MPHA, CPHQ

Vicky Mahn-DiNicola (2/20/2014 at 4:19 PM)
I agree that the data that is collected by the 26 HENS may not be held to robust data integrity standards that physicians and researchers would prefer to see. However, the mission of the HENS was to motivate and accelerate shared learning across facilities. The purpose was not benchmarking. Having said that, since most of the measures collected by the HENS are in fact redundant to other quality reporting programs that do hold to high standards of data integrity (such as "Core" measures, NHSN measures etc.) we might infer that the data collection methodologies are in fact sufficient for hospital comparison purposes. The real issue however is not that the data lacks standardized methodologies for collection and reporting. The greatest challenge is perhaps that these rate based quality measures are simply not designed to show correlations between process and outcome. The next generation of analytics that will arise from machine learning methodologies and unveil correlations between what works and what doesn't work to achieve our desired outcomes will accelerate our learning. Realistically, it will take time to build our health information technology foundations and intraoperability standards. Until then, the clinical collaboratives are helping us take small steps forward until we are ready to leap. Vicky A. Mahn-DiNicola, RN, MS, CPHQ, VP Research & Market Insights, Midas+, A Xerox Company.